Pages that link to "Q35726052"
Jump to navigation
Jump to search
The following pages link to The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival (Q35726052):
Displaying 50 items.
- Protein kinase C signaling and cell cycle regulation (Q21131217) (← links)
- Redox Homeostasis and Cellular Antioxidant Systems: Crucial Players in Cancer Growth and Therapy (Q26740191) (← links)
- Curtailing side effects in chemotherapy: a tale of PKCδ in cisplatin treatment (Q26823867) (← links)
- Rottlerin and cancer: novel evidence and mechanisms (Q27000504) (← links)
- Role of protein kinase C isoforms in bile formation and cholestasis (Q27001101) (← links)
- Protein kinase C delta is phosphorylated on five novel Ser/Thr sites following inducible overexpression in human colorectal cancer cells (Q28255129) (← links)
- PKCδ Sensitizes Neuroblastoma Cells to L-Buthionine-Sulfoximine and Etoposide Inducing Reactive Oxygen Species Overproduction and DNA Damage (Q28477084) (← links)
- Protein kinase C delta negatively regulates tyrosine hydroxylase activity and dopamine synthesis by enhancing protein phosphatase-2A activity in dopaminergic neurons (Q28567412) (← links)
- nPKCepsilon, a P2Y2-R downstream effector in regulated mucin secretion from airway goblet cells (Q28595001) (← links)
- Protein kinase C isoforms: Multi-functional regulators of cell life and death (Q28818259) (← links)
- Decision tree modeling predicts effects of inhibiting contractility signaling on cell motility (Q33281143) (← links)
- Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation (Q33790544) (← links)
- Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR) (Q34044538) (← links)
- Effect of Protein Kinase C delta (PKC-δ) Inhibition on the Transcriptome of Normal and Systemic Sclerosis Human Dermal Fibroblasts In Vitro (Q34077759) (← links)
- Protein kinase C delta (PKCδ) affects proliferation of insulin-secreting cells by promoting nuclear extrusion of the cell cycle inhibitor p21Cip1/WAF1. (Q34116998) (← links)
- PKC-δ mediates interferon-α-induced apoptosis through c-Jun NH2-terminal kinase activation (Q34204603) (← links)
- INTRACELLULAR SIGNALING BY BILE ACIDS. (Q34448448) (← links)
- Trophinin-mediated cell adhesion induces apoptosis of human endometrial epithelial cells through PKC-δ (Q34621052) (← links)
- Protein kinase Cβ2 inhibition reduces hyperglycemia-induced neural tube defects through suppression of a caspase 8-triggered apoptotic pathway (Q34673067) (← links)
- Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma (Q35011925) (← links)
- PKC-delta promotes renal tubular cell apoptosis associated with proteinuria. (Q35153225) (← links)
- Asbestos-induced peribronchiolar cell proliferation and cytokine production are attenuated in lungs of protein kinase C-delta knockout mice (Q35570365) (← links)
- Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer (Q35572426) (← links)
- Formation of Ternary Complex of Human Biliverdin Reductase-Protein Kinase Cδ-ERK2 Protein Is Essential for ERK2-mediated Activation of Elk1 Protein, Nuclear Factor-κB, and Inducible Nitric-oxidase Synthase (iNOS) (Q35668827) (← links)
- Protein kinase C-delta regulates migration and proliferation of vascular smooth muscle cells through the extracellular signal-regulated kinase 1/2. (Q35691430) (← links)
- Protein Kinase C δ Is a Downstream Effector of Oncogenic K-ras in Lung Tumors (Q35733900) (← links)
- Role of ellagic acid in regulation of apoptosis by modulating novel and atypical PKC in lymphoma bearing mice (Q35747051) (← links)
- ERK acts in parallel to PKCδ to mediate the connexin43-dependent potentiation of Runx2 activity by FGF2 in MC3T3 osteoblasts (Q35900708) (← links)
- Protein kinase C delta is essential for optimal macrophage-mediated phagosomal containment of Listeria monocytogenes. (Q36023909) (← links)
- The c-Abl tyrosine kinase controls protein kinase Cδ-induced Fli-1 phosphorylation in human dermal fibroblasts (Q36054245) (← links)
- The human biliverdin reductase-based peptide fragments and biliverdin regulate protein kinase Cδ activity: the peptides are inhibitors or substrate for the protein kinase C. (Q36098076) (← links)
- Emerin is hyperphosphorylated and redistributed in herpes simplex virus type 1-infected cells in a manner dependent on both UL34 and US3. (Q36099092) (← links)
- Analysis of protein kinase C delta (PKC delta) expression in endometrial tumors (Q36334453) (← links)
- PKCδ Regulates Translation Initiation through PKR and eIF2α in Response to Retinoic Acid in Acute Myeloid Leukemia Cells (Q36422120) (← links)
- Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy (Q36528137) (← links)
- Protein kinase C and other diacylglycerol effectors in cancer (Q36769838) (← links)
- Models from experiments: combinatorial drug perturbations of cancer cells (Q36930517) (← links)
- The therapeutic role of targeting protein kinase C in solid and hematologic malignancies (Q36964732) (← links)
- Protein kinase Cdelta expression in breast cancer as measured by real-time PCR, western blotting and ELISA. (Q36977510) (← links)
- PKC signaling prevents irradiation-induced apoptosis of primary human fibroblasts (Q37073602) (← links)
- Protein kinase C signalling in leukemia (Q37208502) (← links)
- Rab7 activation by growth factor withdrawal contributes to the induction of apoptosis (Q37225961) (← links)
- Novel role of protein kinase C-delta Tyr 311 phosphorylation in vascular smooth muscle cell hypertrophy by angiotensin II. (Q37308263) (← links)
- Regulation of protein kinase C delta downregulation by protein kinase C epsilon and mammalian target of rapamycin complex 2. (Q37356531) (← links)
- Protein kinase Cδ and caspase‐3 modulate TRAIL‐induced apoptosis in breast tumor cells (Q37451204) (← links)
- Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors (Q37513179) (← links)
- Emerging biomarkers in breast cancer care (Q37779305) (← links)
- Challenges to the development of bryostatin-type anticancer drugs based on the activation mechanism of protein kinase Cδ. (Q38005950) (← links)
- Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy (Q38127618) (← links)
- Synthesis and biological activities of simplified analogs of the natural PKC ligands, bryostatin-1 and aplysiatoxin (Q38200047) (← links)